Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists
- PMID: 28464558
- PMCID: PMC5668199
- DOI: 10.1002/acr.23273
Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists
Abstract
Objective: To compare practice patterns and prescribing differences for juvenile idiopathic arthritis (JIA) between adult rheumatologists (ARs) and pediatric rheumatologists (PRs), the perceived educational needs, and factors that enhance or impede co-management.
Methods: Two parallel, cross-sectional surveys focusing on JIA were administered in 2009 to a random sample of 193 PRs and 500 ARs using the American College of Rheumatology membership file. Bivariate analysis was conducted for common items.
Results: The response rate was 62.1% for ARs (n = 306) and 72.3% for PRs (n = 138). Only 23% of responding ARs (n = 69) reported caring for children with JIA. Of these, 94% strongly agreed/agreed feeling comfortable diagnosing JIA; however, only 76% felt comfortable treating JIA. Clinical vignettes highlighted several prescribing differences. Forty-eight percent of ARs and 31% of PRs felt medications to treat JIA did not have clear dosing guidelines. Though PRs initiated disease-modifying antirheumatic drugs and biologic agents earlier, treatments were similar after 3 months. To enhance co-management, 74% of pediatric respondents endorsed shared medical records.
Conclusion: Nearly one-quarter of surveyed ARs care for children with JIA, with most limiting their practice to older children. There was more discomfort in treating JIA than diagnosing it, and there were significant prescribing differences. Both provider types identified the need for better dosing and treatment resources. Updated management guidelines along with exposure to pediatric rheumatology in fellowship could reduce treatment differences and enhance the care of children with JIA. Shared medical records and improvement in reimbursement may optimize co-management.
© 2017, American College of Rheumatology.
Figures
Comment in
-
Differences in Management Style Between Pediatric and Adult Rheumatologists: Comment on the Article by Van Mater et al.Arthritis Care Res (Hoboken). 2019 Apr;71(4):578. doi: 10.1002/acr.23552. Arthritis Care Res (Hoboken). 2019. PMID: 29481725 No abstract available.
Similar articles
-
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists.Pediatr Rheumatol Online J. 2020 Jul 13;18(1):57. doi: 10.1186/s12969-020-00445-6. Pediatr Rheumatol Online J. 2020. PMID: 32660497 Free PMC article.
-
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.J Rheumatol. 2017 Mar;44(3):352-360. doi: 10.3899/jrheum.161078. Epub 2017 Feb 1. J Rheumatol. 2017. PMID: 28148696 Free PMC article.
-
Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).Semin Arthritis Rheum. 2016 Oct;46(2):190-195. doi: 10.1016/j.semarthrit.2016.06.001. Epub 2016 Jun 8. Semin Arthritis Rheum. 2016. PMID: 27422803 Free PMC article.
-
Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2017 Nov 7;15(1):78. doi: 10.1186/s12969-017-0206-9. Pediatr Rheumatol Online J. 2017. PMID: 29116003 Free PMC article. Review.
-
Rheumatology practice in Japan: challenges and opportunities.Rheumatol Int. 2019 Sep;39(9):1499-1505. doi: 10.1007/s00296-019-04281-0. Epub 2019 Mar 19. Rheumatol Int. 2019. PMID: 30888472 Review.
Cited by
-
Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients With Juvenile Idiopathic Arthritis.J Pediatr Pharmacol Ther. 2021;26(2):157-162. doi: 10.5863/1551-6776-26.2.157. Epub 2021 Feb 15. J Pediatr Pharmacol Ther. 2021. PMID: 33603579 Free PMC article.
-
American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases.Arthritis Care Res (Hoboken). 2025 Aug;77(8):953-964. doi: 10.1002/acr.25519. Epub 2025 May 5. Arthritis Care Res (Hoboken). 2025. PMID: 40051122 Free PMC article.
References
-
- Sacks JJ, Helmick CG, Luo YH, Ilowite NT, Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001–2004. Arthritis Rheum. 2007;57:1439–45. - PubMed
-
- A Study of the Supply and Demand for Pediatric Rheumatologists. https://pdfs.semanticscholar.org/4f1d/41eec3b2ecbe7e529efb169cdb0d82c0a9....
-
- Mayer ML, Sandborg CI, Mellins ED. Role of pediatric and internist rheumatologists in treating children with rheumatic diseases. Pediatrics. 2004;113:173–81. - PubMed
-
- DeWitt EM, Sherry DD, Cron RQ. Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders. J Clin Rheumatol. 2005;11:21–33. - PubMed
-
- Milojevic DS, Ilowite NT. Treatment of rheumatic diseases in children: special considerations. Rheum Dis Clin North Am. 2002;28:461–82. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical